Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

January 21st, 2020

Cook Medical awarded new contract with Veterans Affairs for endovascular medical devices

Bloomington, Ind.—Cook Medical is pleased to announce a new contract with the US Department of Veterans Affairs (VA). The contract, which went into effect on October 21, 2019, includes products such as the Zilver® PTX® Drug-Eluting Peripheral Stent, Zenith® aortic endografts, and associated interventional devices to treat patients with vascular disease.

This contract will assist the VA supply chain team in streamlining the process for procuring medical devices for contracted products. Physicians working with VA now have increased access to Cook Medical’s endovascular devices. This also means that physicians working at VA facilities across the country have more options when selecting devices for treating their patients.

“Cook has always been a market leader in the development of our endovascular portfolio, and we are thrilled to now provide these life-saving technologies to the country’s Veterans via this new contract. Cook has always valued serving members of local communities, and we are especially pleased to align with VA to better care for those who have served our country,” said John Blackketter, North American Manager of Cook Medical’s BusinessCare Integration team.

About Veterans Affairs
The United States Department of Veterans Affairs is a federal agency dedicated to providing quality healthcare for our country’s Veterans. VA is founded on core values of integrity, commitment, advocacy, respect, and excellence when treating and supporting Veterans and their families.

About Cook Medical
Since 1963, Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at, and for the latest news, follow us on TwitterFacebook and LinkedIn.